Logo image of GTHX

G1 THERAPEUTICS INC (GTHX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:GTHX - US3621LQ1099 - Common Stock

7.15 USD
0 (0%)
Last: 9/17/2024, 8:10:49 PM
7.14 USD
-0.01 (-0.14%)
After Hours: 9/17/2024, 8:10:49 PM
Fundamental Rating

2

Overall GTHX gets a fundamental rating of 2 out of 10. We evaluated GTHX against 525 industry peers in the Biotechnology industry. GTHX may be in some trouble as it scores bad on both profitability and health. GTHX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • GTHX had negative earnings in the past year.
  • GTHX had a negative operating cash flow in the past year.
  • In the past 5 years GTHX always reported negative net income.
  • GTHX had a negative operating cash flow in each of the past 5 years.
GTHX Yearly Net Income VS EBIT VS OCF VS FCFGTHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -50M -100M

1.2 Ratios

  • The Return On Assets of GTHX (-45.36%) is comparable to the rest of the industry.
  • The Return On Equity of GTHX (-182.03%) is worse than 67.14% of its industry peers.
Industry RankSector Rank
ROA -45.36%
ROE -182.03%
ROIC N/A
ROA(3y)-58.78%
ROA(5y)-52.55%
ROE(3y)-151.24%
ROE(5y)-111.52%
ROIC(3y)N/A
ROIC(5y)N/A
GTHX Yearly ROA, ROE, ROICGTHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150 -200

1.3 Margins

  • With an excellent Gross Margin value of 89.44%, GTHX belongs to the best of the industry, outperforming 92.44% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for GTHX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GTHX Yearly Profit, Operating, Gross MarginsGTHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

2

2. Health

2.1 Basic Checks

  • GTHX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for GTHX has been increased compared to 1 year ago.
  • Compared to 1 year ago, GTHX has a worse debt to assets ratio.
GTHX Yearly Shares OutstandingGTHX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
GTHX Yearly Total Debt VS Total AssetsGTHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -8.24, we must say that GTHX is in the distress zone and has some risk of bankruptcy.
  • GTHX has a Altman-Z score of -8.24. This is in the lower half of the industry: GTHX underperforms 72.76% of its industry peers.
  • A Debt/Equity ratio of 1.34 is on the high side and indicates that GTHX has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.34, GTHX is doing worse than 80.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.34
Debt/FCF N/A
Altman-Z -8.24
ROIC/WACCN/A
WACC11.45%
GTHX Yearly LT Debt VS Equity VS FCFGTHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.48 indicates that GTHX has no problem at all paying its short term obligations.
  • GTHX has a worse Current ratio (2.48) than 71.53% of its industry peers.
  • GTHX has a Quick Ratio of 2.12. This indicates that GTHX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of GTHX (2.12) is worse than 73.81% of its industry peers.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 2.12
GTHX Yearly Current Assets VS Current LiabilitesGTHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

5

3. Growth

3.1 Past

  • GTHX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.71%, which is quite impressive.
  • The Revenue for GTHX has decreased by -34.74% in the past year. This is quite bad
  • The Revenue has been growing by 22.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)49.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-171.43%
Revenue 1Y (TTM)-34.74%
Revenue growth 3Y22.13%
Revenue growth 5YN/A
Sales Q2Q%-60.97%

3.2 Future

  • The Earnings Per Share is expected to grow by 20.36% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, GTHX will show a quite strong growth in Revenue. The Revenue will grow by 15.53% on average per year.
EPS Next Y55.71%
EPS Next 2Y43.4%
EPS Next 3Y30.77%
EPS Next 5Y20.36%
Revenue Next Year-8.96%
Revenue Next 2Y8.16%
Revenue Next 3Y10.3%
Revenue Next 5Y15.53%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
GTHX Yearly Revenue VS EstimatesGTHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
GTHX Yearly EPS VS EstimatesGTHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2 -3

2

4. Valuation

4.1 Price/Earnings Ratio

  • GTHX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 133.52, the valuation of GTHX can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GTHX indicates a rather cheap valuation: GTHX is cheaper than 90.86% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 25.96. GTHX is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 133.52
GTHX Price Earnings VS Forward Price EarningsGTHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GTHX Per share dataGTHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • GTHX's earnings are expected to grow with 30.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.4%
EPS Next 3Y30.77%

0

5. Dividend

5.1 Amount

  • GTHX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

G1 THERAPEUTICS INC / GTHX FAQ

Can you provide the ChartMill fundamental rating for G1 THERAPEUTICS INC?

ChartMill assigns a fundamental rating of 2 / 10 to GTHX.


Can you provide the valuation status for G1 THERAPEUTICS INC?

ChartMill assigns a valuation rating of 2 / 10 to G1 THERAPEUTICS INC (GTHX). This can be considered as Overvalued.


How profitable is G1 THERAPEUTICS INC (GTHX) stock?

G1 THERAPEUTICS INC (GTHX) has a profitability rating of 1 / 10.


What is the financial health of G1 THERAPEUTICS INC (GTHX) stock?

The financial health rating of G1 THERAPEUTICS INC (GTHX) is 2 / 10.